SK211290A3 - Octapeptide and therapeutical agent containing the same - Google Patents

Octapeptide and therapeutical agent containing the same Download PDF

Info

Publication number
SK211290A3
SK211290A3 SK2112-90A SK211290A SK211290A3 SK 211290 A3 SK211290 A3 SK 211290A3 SK 211290 A SK211290 A SK 211290A SK 211290 A3 SK211290 A3 SK 211290A3
Authority
SK
Slovakia
Prior art keywords
phe
ala
hydroxyl
methoxy
trp
Prior art date
Application number
SK2112-90A
Other languages
English (en)
Slovak (sk)
Other versions
SK279231B6 (sk
Inventor
David H Coy
William A Murphy
Original Assignee
Univ Tulane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tulane filed Critical Univ Tulane
Publication of SK279231B6 publication Critical patent/SK279231B6/sk
Publication of SK211290A3 publication Critical patent/SK211290A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK2112-90A 1989-04-26 1990-04-26 Octapeptide and therapeutical agent containing the same SK211290A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34332589A 1989-04-26 1989-04-26

Publications (2)

Publication Number Publication Date
SK279231B6 SK279231B6 (sk) 1998-08-05
SK211290A3 true SK211290A3 (en) 1998-08-05

Family

ID=23345640

Family Applications (1)

Application Number Title Priority Date Filing Date
SK2112-90A SK211290A3 (en) 1989-04-26 1990-04-26 Octapeptide and therapeutical agent containing the same

Country Status (14)

Country Link
EP (1) EP0395417B1 (fr)
JP (1) JP2882679B2 (fr)
KR (1) KR0173119B1 (fr)
AT (1) ATE118222T1 (fr)
CA (1) CA2053250A1 (fr)
CZ (1) CZ284341B6 (fr)
DD (1) DD293832A5 (fr)
DE (1) DE69016691T2 (fr)
DK (1) DK0395417T3 (fr)
ES (1) ES2069684T3 (fr)
HU (1) HU217636B (fr)
IE (1) IE66113B1 (fr)
SK (1) SK211290A3 (fr)
WO (1) WO1990012811A1 (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE920416A1 (en) * 1991-02-08 1992-08-12 Biomeasure Method of treating benign and malignant proliferative skin¹disease
US5783170A (en) * 1991-11-27 1998-07-21 Diatide, Inc. Peptide-metal chelate conjugates
US5716596A (en) * 1992-06-23 1998-02-10 Diatide, Inc. Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses
US5871711A (en) * 1992-06-23 1999-02-16 Diatide, Inc. Radioactively-labeled somatostatin-derived peptides for imaging and therapeutic uses
US5620675A (en) * 1992-06-23 1997-04-15 Diatech, Inc. Radioactive peptides
US6017512A (en) * 1992-06-23 2000-01-25 Diatide, Inc. Radiolabeled peptides
CA2118588A1 (fr) * 1992-07-27 1994-02-03 David H. Coy Antagoniste des recepteurs a neuromedine b
US5569741A (en) * 1992-07-27 1996-10-29 Biomeasure, Inc. Cyclic octapeptide neuromedin B receptor antagonists
US5462926A (en) * 1992-07-27 1995-10-31 Biomeasure, Inc. Neuromedin B receptor antagonists which demonstrate selectivity
US6051206A (en) * 1994-06-03 2000-04-18 Diatide, Inc Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
US5770687A (en) * 1995-06-07 1998-06-23 Peptor Limited Comformationally constrained backbone cyclized somatostatin analogs
US6051554A (en) * 1995-06-07 2000-04-18 Peptor Limited Conformationally constrained backbone cyclized somatostatin analogs
MY147327A (en) * 1995-06-29 2012-11-30 Novartis Ag Somatostatin peptides
JP3869874B2 (ja) * 1995-11-15 2007-01-17 大日本住友製薬株式会社 急性肝不全治療剤
US6841533B1 (en) 1995-12-07 2005-01-11 Peptor Limited Conformationally constrained backbone cyclized interleukin-6 antagonists
US5686418A (en) * 1996-04-08 1997-11-11 Biomeasure Incorporated Prolonging survival of transplanted pancreatic cells
WO1998008528A1 (fr) 1996-08-30 1998-03-05 Biomeasure Incorporated Procede d'inhibition de la fibrose avec un agoniste de la somatostatine
US6262229B1 (en) 1996-12-04 2001-07-17 Biomeasure Incorporated Somatostatin antagonists
RU2179172C2 (ru) * 1996-12-04 2002-02-10 Сосьете Де Консей Де Решерш Э Д'Аппликасьон Сьентифик С.А. (С.К.Р.А.С.) Антагонисты рецепторов соматостатина
WO1998051331A1 (fr) 1997-05-13 1998-11-19 Societe De Conseils De Recherches Et D'applications Scientifiques S.A. (S.C.R.A.S.) Somatostatine et agonistes de somatostatine servant a la reduction du poids corporel
US6004928A (en) * 1997-05-13 1999-12-21 Biomeasure, Incorporated Method of treating hyperlipidemia
US7026289B2 (en) 1997-05-13 2006-04-11 Societe De Conseils De Recherches Et D'applications Scientifiques, Sas Method and compositions for treating hyperlipidemia and other conditions
US5968903A (en) * 1998-05-07 1999-10-19 Biomeasure, Incorporated Inhibition of H. pylori proliferation
US6124263A (en) * 1998-11-16 2000-09-26 Asta Medica Ag Treatment of tumors by administration of growth hormone releasing compounds and their antagonists
SE9804064D0 (sv) * 1998-11-25 1998-11-25 A & Science Invest Ab Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
US6903074B1 (en) 1999-06-04 2005-06-07 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Neuromedin b and somatostatin receptor agonists
GB0018891D0 (en) 2000-08-01 2000-09-20 Novartis Ag Organic compounds
CN1541102A (zh) * 2001-04-09 2004-10-27 生长激素抑制素激动剂
JP3996897B2 (ja) 2001-06-08 2007-10-24 ソシエテ・ドゥ・コンセイユ・ドゥ・ルシェルシュ・エ・ダプリカーション・シャンティフィック・エス・ア・エス ソマトスタチン−ドーパミンキメラ類似体
AU2004232314B2 (en) 2003-04-22 2007-11-22 Ipsen Pharma S.A.S. Peptide vectors
JP5799397B2 (ja) 2008-06-12 2015-10-28 イプセン・バイオイノベーション・リミテッドＩｐｓｅｎ Ｂｉｏｉｎｎｏｖａｔｉｏｎ Ｌｉｍｉｔｅｄ 癌の抑制
EP3590956A1 (fr) 2008-06-12 2020-01-08 Ipsen Bioinnovation Limited Suppression de maladies neuroendocrines
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer
AU2014280847B2 (en) 2013-06-13 2019-07-04 Antisense Therapeutics Ltd Combination therapy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU78191A1 (de) * 1977-09-28 1979-05-25 Ciba Geigy Ag Verfahren zur herstellung von neuen cyclopeptiden
US4185010A (en) * 1978-12-12 1980-01-22 American Home Products Corporation Nonapeptides
US4369179A (en) * 1979-12-14 1983-01-18 Ciba-Geigy Corporation Acylpeptides
FR2567524B1 (fr) * 1984-07-10 1987-11-27 Sanofi Sa Procede de synthese de la somatocrinine en phase liquide et peptides intermediaires
HUT42101A (en) * 1985-01-07 1987-06-29 Sandoz Ag Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds
US4871717A (en) * 1987-01-07 1989-10-03 Administrators Of The Tulane Educational Fund Peptides
JP2568228B2 (ja) * 1987-02-03 1996-12-25 ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド 治療用ソマトスタチンアナログ
CH679045A5 (fr) * 1987-06-29 1991-12-13 Sandoz Ag
JP2809403B2 (ja) * 1987-07-07 1998-10-08 ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド 治療用ソマトスタチンアナログ化合物

Also Published As

Publication number Publication date
SK279231B6 (sk) 1998-08-05
CA2053250A1 (fr) 1990-10-27
IE66113B1 (en) 1995-12-13
DD293832A5 (de) 1991-09-12
ES2069684T3 (es) 1995-05-16
HU217636B (hu) 2000-03-28
KR0173119B1 (ko) 1999-02-01
DE69016691T2 (de) 1995-10-05
HU904481D0 (en) 1992-02-28
JP2882679B2 (ja) 1999-04-12
EP0395417B1 (fr) 1995-02-08
JPH04504723A (ja) 1992-08-20
DE69016691D1 (de) 1995-03-23
DK0395417T3 (da) 1995-06-12
ATE118222T1 (de) 1995-02-15
IE901476L (en) 1990-10-26
CZ284341B6 (cs) 1998-10-14
KR920700226A (ko) 1992-02-19
HUT60287A (en) 1992-08-28
EP0395417A1 (fr) 1990-10-31
CZ211290A3 (en) 1995-03-15
WO1990012811A1 (fr) 1990-11-01

Similar Documents

Publication Publication Date Title
SK211290A3 (en) Octapeptide and therapeutical agent containing the same
US4871717A (en) Peptides
US4853371A (en) Therapeutic somatostatin analogs
US4904642A (en) Therapeutic somatostatin analogs
KR100325972B1 (ko) 치료성펩타이드유도체
JP6211418B2 (ja) 糖鎖付加ポリペプチドおよび当該ポリペプチドを含む医薬組成物
EP0389180B1 (fr) Peptides et leur emploi en thérapie
EP0859785B1 (fr) Analogues peptides cycliques de somatostatine
EP0215171A2 (fr) Peptides
US5633263A (en) Linear somatostatin analogs
AU602657B2 (en) Therapeutic somatostatin analogs
JP6178238B2 (ja) 糖鎖付加ポリペプチドおよび当該ポリペプチドを含む医薬組成物
JP2809403B2 (ja) 治療用ソマトスタチンアナログ化合物
Lewis et al. The superior therapeutic properties of som230 originate from unique structural elements
ITMI20072266A1 (it) Nuovi analoghi non selettivi di somatostatina
AU1136000A (en) Cyclic peptide analogs of somatostatin